Buspirone potentiation of antidepressants in the treatment of PTSD.
Hamner
M
M
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, R.H. Johnson VAMC (116), Charleston 29401, USA.
Ulmer
H
H
Horne
D
D
D000328:Adult; D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002065:Buspirone / Q000009:adverse effects / Q000627:therapeutic use*; D003130:Combat Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome; D014728:Veterans / Q000523:psychology*; D014744:Vietnam
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D002065:Buspirone; D017367:Selective Serotonin Reuptake Inhibitors